Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.32 |
| ▸ | LTA4H | P09960 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21793380 | 0.91 | MEN1 (0.36) | MEN1MAPTKMT2AL3MBTL1PDK2 | |
| SCHEMBL21793375 | 0.86 | MEN1 (0.39) | MEN1MAPTKMT2AL3MBTL1PDK2 | |
| SCHEMBL29523937 | 0.86 | MEN1 (0.39) | MEN1MAPTKMT2AL3MBTL1PDK2 | |
| SCHEMBL21793203 | 0.86 | MEN1 (0.35) | MEN1MAPTKMT2AL3MBTL1 | |
| SCHEMBL29403730 | 0.85 | MAPK1 (0.38) | MEN1MAPTKMT2AL3MBTL1PDK2 | |
| SCHEMBL19149291 | 0.85 | MAPK1 (0.38) | MEN1MAPTKMT2AL3MBTL1PDK2 | |
| SCHEMBL13910177 | 0.82 | PDK2 (0.43) | MEN1MAPTKMT2AL3MBTL1PDK2 | |
| SCHEMBL21793376 | 0.82 | MEN1 (0.37) | MEN1MAPTKMT2AL3MBTL1PDK2 | |
| SCHEMBL23713945 | 0.80 | PDK2 (0.39) | MEN1MAPTKMT2AL3MBTL1PDK2 | |
| SCHEMBL21793629 | 0.80 | PDK2 (0.41) | MEN1MAPTKMT2AL3MBTL1PDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11472966-B2 | Coating composition, organic light-emitting diode using same and method for preparing same | LG CHEM, LTD. | 2022-10-18 | — | — | US | disclosed |
| US-11377570-B2 | Ink composition for organic light emitting device | LG CHEM, LTD. | 2022-07-05 | — | — | US | disclosed |
| US-11274213-B2 | Compound, coating composition comprising same, organic light-emitting diode using same, and method for preparing same | LG CHEM, LTD. | 2022-03-15 | — | — | US | disclosed |
| US-20200308435-A1 | Ink Composition for Organic Light Emitting Device | LG CHEM, LTD. (KR) | 2020-10-01 | — | — | US | disclosed |
| US-20200259095-A1 | Compound, Coating Composition Comprising Same, Organic Light-Emitting Diode Using Same, and Method for Preparing Same | LG CHEM, LTD. (KR) | 2020-08-13 | — | — | US | disclosed |
| WO-2020045904-A1 | INK COMPOSITION FOR ORGANIC LIGHT-EMITTING DEVICE | 주식회사 엘지화학 | 2020-03-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200259095-A1 | Compound, Coating Composition Comprising Same, Organic Light-Emitting Diode Using Same, and Method for Preparing Same | SEM1, SETDB1, ORMDL3 | MEN1 601/4885MAPT 268/4885KMT2A 722/4885 |
| US-11472966-B2 | Coating composition, organic light-emitting diode using same and method for preparing same | OR10J3, SEM1, ORMDL3 | MEN1 1096/4885MAPT 291/4885KMT2A 1418/4885 |
| US-11274213-B2 | Compound, coating composition comprising same, organic light-emitting diode using same, and method for preparing same | SEM1, SETDB1, ORMDL3 | MEN1 601/4885MAPT 268/4885KMT2A 722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.